GLP-1's (excluding those combined insulin) - dmd
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- 2023 8.1.0
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/glp-1s-excluding-those-combined-insulin-dmd
- Version ID
- 1e9c394a
Versions
- 1e9c394a
Description
This codelist contains NHS Dictionary of Medicines and Devices (dm+d) codes for GLP-1 mimetics, excluding products which are combined with insulin. Note that some GLP-1 products are licenced for the indication of diabetes and some for the indication of weight loss; all indications are included in this codelist.
Methodology
Converted from pseudo-BNF system codelist
References
Signed off by
- Andrew Brown, (Aug. 15, 2023)
- Chris Wood, (Aug. 15, 2023)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| dmd_type | dmd_id | dmd_name | bnf_code |
|---|---|---|---|
| VMP | 15859111000001102 | Liraglutide 6mg/ml solution for injection 3ml pre-filled disposable devices | 0601023ABAAAAAA |
| AMP | 15858611000001101 | Victoza 6mg/ml solution for injection 3ml pre-filled pens | 0601023ABBBAAAA |
| AMP | 33747711000001102 | Saxenda 6mg/ml solution for injection 3ml pre-filled pens | 0601023ABBCAAAA |
| VMP | 21994811000001105 | Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | 0601023AIAAAAAA |
| VMP | 21994611000001106 | Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | 0601023AIAAABAB |
| VMP | 21994711000001102 | Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices and Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | 0601023AIAAACAC |
| AMP | 21941011000001105 | Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pens | 0601023AIBBAAAA |
| AMP | 21941511000001102 | Lyxumia 10micrograms/0.2ml solution for injection 3ml pre-filled pens | 0601023AIBBABAB |
| AMP | 21953711000001106 | Lyxumia 10micrograms/20micrograms treatment initiation pack | 0601023AIBBACAC |
| VMP | 28789611000001108 | Dulaglutide 0.75mg/0.5ml solution for injection pre-filled disposable devices | 0601023AQAAAAAA |
| VMP | 28789711000001104 | Dulaglutide 1.5mg/0.5ml solution for injection pre-filled disposable devices | 0601023AQAAABAB |
| VMP | 39233411000001108 | Dulaglutide 3mg/0.5ml solution for injection pre-filled disposable devices | 0601023AQAAACAC |
| VMP | 39233511000001107 | Dulaglutide 4.5mg/0.5ml solution for injection pre-filled disposable devices | 0601023AQAAADAD |
| AMP | 28461011000001109 | Trulicity 0.75mg/0.5ml solution for injection pre-filled pens | 0601023AQBBAAAA |
| AMP | 28462311000001103 | Trulicity 1.5mg/0.5ml solution for injection pre-filled pens | 0601023AQBBABAB |
| AMP | 39232411000001104 | Trulicity 3mg/0.5ml solution for injection pre-filled pens | 0601023AQBBACAC |
| AMP | 39232611000001101 | Trulicity 4.5mg/0.5ml solution for injection pre-filled pens | 0601023AQBBADAD |
| VMP | 36490911000001109 | Semaglutide 0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable device | 0601023AWAAAAAA |
| VMP | 36491011000001101 | Semaglutide 0.5mg/0.37ml solution for injection 1.5ml pre-filled disposable device | 0601023AWAAABAB |
| VMP | 36491111000001100 | Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable device | 0601023AWAAACAC |
| VMP | 38840111000001100 | Semaglutide 14mg tablets | 0601023AWAAADAD |
| VMP | 38840211000001106 | Semaglutide 3mg tablets | 0601023AWAAAEAE |
| VMP | 38840311000001103 | Semaglutide 7mg tablets | 0601023AWAAAFAF |
| AMP | 36470811000001107 | Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens | 0601023AWBBAAAA |
| AMP | 36471111000001106 | Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens | 0601023AWBBABAB |
| AMP | 36471411000001101 | Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens | 0601023AWBBACAC |
| AMP | 38732411000001108 | Rybelsus 14mg tablets | 0601023AWBCAAAD |
| AMP | 38731811000001101 | Rybelsus 3mg tablets | 0601023AWBCABAE |
| AMP | 38732111000001103 | Rybelsus 7mg tablets | 0601023AWBCACAF |
| VMP | 41152511000001108 | Tirzepatide 2.5mg/0.5ml solution for injection pre-filled disposable devices | 0601023AZAAAAAA |
| VMP | 41152611000001107 | Tirzepatide 5mg/0.5ml solution for injection pre-filled disposable devices | 0601023AZAAABAB |
| AMP | 41126111000001104 | Mounjaro 2.5mg/0.5ml solution for injection pre-filled pens | 0601023AZBBAAAA |
| AMP | 41126511000001108 | Mounjaro 5mg/0.5ml solution for injection pre-filled pens | 0601023AZBBABAB |
| VMP | 11494211000001108 | Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices | 0601023Y0AAAAAA |
| VMP | 11494111000001102 | Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices | 0601023Y0AAABAB |
| VMP | 19275411000001107 | Exenatide 2mg powder and solvent for prolonged-release suspension for injection vials | 0601023Y0AAACAC |
| VMP | 28440211000001102 | Exenatide 2mg powder and solvent for prolonged-release suspension for injection pre-filled disposable devices | 0601023Y0AAADAD |
| VMP | 38082811000001104 | Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices | 0601023Y0AAAEAE |
| AMP | 11494811000001109 | Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens | 0601023Y0BBAAAA |
| AMP | 11494611000001105 | Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens | 0601023Y0BBABAB |
| AMP | 19274811000001108 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials | 0601023Y0BCAAAC |
| AMP | 28426011000001108 | Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens | 0601023Y0BCABAD |
| AMP | 38060511000001101 | Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens | 0601023Y0BCACAE |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.